Pregnancy Related

0
Pipeline Programs
9
Companies
8
Clinical Trials
3 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

7 companies ranked by most advanced pipeline stage

Allergy Therapeutics
Allergy TherapeuticsUK - West Sussex
2 programs
EMBRACE (Evaluation of Maternal and Baby Outcome Registry After Chemoprophylactic Exposure)N/A1 trial
Microbiome and Malnutrition in PregnancyN/A1 trial
Active Trials
NCT01209754CompletedEst. May 2020
NCT04992104RecruitingEst. Mar 2027
City Therapeutics
City TherapeuticsMA - Cambridge
1 program
Alternate Nostril BreathingN/A1 trial
Active Trials
NCT05341921CompletedEst. Dec 2024
AbbVie
AbbVieNORTH CHICAGO, IL
1 program
Chama cha MamaTotoN/A1 trial
Active Trials
NCT03187873Unknown3,040Est. Dec 2018
Mission Therapeutics
Mission TherapeuticsUK - Cambridge
1 program
Elective InductionN/A1 trial
Active Trials
NCT04597528Completed315Est. May 2021
Design Therapeutics
1 program
Fourth Trimester Mobile ToolN/A1 trial
Active Trials
NCT04475718CompletedEst. Dec 2021
Harmony Biosciences
Harmony BiosciencesPLYMOUTH MEETING, PA
1 program
PitolisantN/A1 trial
Active Trials
NCT05536011Recruiting1,329Est. Jun 2030
Alliance Pharmaceuticals
1 program
The Heartland StudyN/A1 trial
Active Trials
NCT05492708Recruiting2,600Est. Jan 2029

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Allergy TherapeuticsMicrobiome and Malnutrition in Pregnancy
City TherapeuticsAlternate Nostril Breathing
Harmony BiosciencesPitolisant
Design TherapeuticsFourth Trimester Mobile Tool
Alliance PharmaceuticalsThe Heartland Study
Mission TherapeuticsElective Induction
AbbVieChama cha MamaToto
Allergy TherapeuticsEMBRACE (Evaluation of Maternal and Baby Outcome Registry After Chemoprophylactic Exposure)

Clinical Trials (8)

Total enrollment: 7,284 patients across 8 trials

NCT04992104Allergy TherapeuticsMicrobiome and Malnutrition in Pregnancy

Microbiome and Malnutrition in Pregnancy

Start: Feb 2023Est. completion: Mar 2027
N/ARecruiting
NCT05341921City TherapeuticsAlternate Nostril Breathing

Deep Breathing Techniques (Pranayama) in Pregnancy

Start: Aug 2022Est. completion: Dec 2024
N/ACompleted
NCT05536011Harmony BiosciencesPitolisant

WAKIX® (Pitolisant) Pregnancy Registry

Start: Aug 2021Est. completion: Jun 20301,329 patients
N/ARecruiting
NCT04475718Design TherapeuticsFourth Trimester Mobile Tool

Fourth Trimester - A Web-based Tool for Postpartum Care to Address the Needs of Underserved Women

Start: May 2021Est. completion: Dec 2021
N/ACompleted
NCT05492708Alliance PharmaceuticalsThe Heartland Study

The Heartland Study

Start: Jan 2020Est. completion: Jan 20292,600 patients
N/ARecruiting
NCT04597528Mission TherapeuticsElective Induction

Elective Induction of Labour at Thirty Nine Weeks: a Prospective Observational Study

Start: Oct 2019Est. completion: May 2021315 patients
N/ACompleted
NCT03187873AbbVieChama cha MamaToto

Chamas for Change Validation

Start: May 2017Est. completion: Dec 20183,040 patients
N/AUnknown
NCT01209754Allergy TherapeuticsEMBRACE (Evaluation of Maternal and Baby Outcome Registry After Chemoprophylactic Exposure)

EMBRACE (Evaluation of Maternal and Baby Outcome Registry After Chemoprophylactic Exposure)

Start: Oct 2009Est. completion: May 2020
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 actively recruiting trials targeting 7,284 patients
9 companies competing in this space